Search Results

Iodine radioactive: Acute myeloid leukaemia: case report

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 22-23(2)

Publisher: Adis International

Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders

Authors: Basquiera, Ana L.; Soria, Néstor W.; Ryser, Ricardo; Salguero, Miriam; Moiraghi, Beatriz; Sackmann, Federico; Sturich, Ana G.; Borello, Adriana; Berretta, Adriana; Bonafé, Miriam; Barral, José Moreno; Palazzo, Emilio D.; García, Juan J.

Source: Hematology, Volume 14, Number 6, December 2009 , pp. 323-330(8)

Publisher: Maney Publishing

Ofatumumab [Arzerra] and romidepsin [istodax] are now included in the Clinical Practice Guidelines in Oncology

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 592, 2009-11-28 , pp. 2-2(1)

Publisher: Adis International

Intravascular lymphocytosis in acute appendicitis: potential mimicry of chronic lymphocytic leukaemia

Authors: Lee, Sandra; Ogilvie, Robert T; Dupre, Marc; Gao, Zu-Hua

Source: Histopathology, Volume 55, Number 6, December 2009 , pp. 660-664(5)

Publisher: Blackwell Publishing

Cefepime is not associated with an increased risk of mortality in paediatric patients with newly diagnosed acute myeloid leukaemia

Source: Reactions, Volume 1, Number 1280, 2009-11-28 , pp. 6-6(1)

Publisher: Adis International

Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes

Authors: Bradstock, K.; Hertzberg, M.; Kerridge, I.; Svennilson, J.; George, B.; McGurgan, M.; Huang, G.; Antonenas, V.; Gottlieb, D.

Source: Internal Medicine Journal, Volume 39, Number 11, November 2009 , pp. 744-751(8)

Publisher: Blackwell Publishing

The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service

Authors: Wells, A. W.; Llewelyn, C. A.; Casbard, A.; Johnson, A. J.; Amin, M.; Ballard, S.; Buck, J.; Malfroy, M.; Murphy, M. F.; Williamson, L. M.

Source: Transfusion Medicine, Volume 19, Number 6, December 2009 , pp. 315-328(14)

Publisher: Blackwell Publishing

Interleukin-24: A Molecule with Potential Anti-Cancer Activity and a Cytokine in Search of a Function

Authors: Dalloul, Ali; Sainz-Perez, Alexander

Source: Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Dru, Volume 9, Number 4, December 2009 , pp. 353-360(8)

Publisher: Bentham Science Publishers

The allogeneic graft-versus-cancer effect

Authors: Ringdén, Olle; Karlsson, Helen; Olsson, Richard; Omazic, Brigitta; Uhlin, Michael

Source: British Journal of Haematology, Volume 147, Number 5, December 2009 , pp. 614-633(20)

Publisher: Blackwell Publishing

Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine: a potential marker of defective damage response

Authors: de Viron, Emeline; Knoops, Laurent; Connerotte, Thierry; Smal, Caroline; Michaux, Lucienne; Saussoy, Pascale; Vannuffel, Pascal; Beert, Eline; Vekemans, Marie-Christiane; Hermans, Cédric; Bontemps, Françoise; Van Den Neste, Eric

Source: British Journal of Haematology, Volume 147, Number 5, December 2009 , pp. 641-652(12)

Publisher: Blackwell Publishing

FLT3-ITD expression levels and their effect on STAT5 in AML with and without NPM mutations

Authors: Seedhouse, Claire H.; Pallis, Monica; Grundy, Martin; Shang, Shili; Russell, Nigel H.

Source: British Journal of Haematology, Volume 147, Number 5, December 2009 , pp. 653-661(9)

Publisher: Blackwell Publishing

A Phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL)

Authors: Pulsipher, Michael A.; Wall, Donna A.; Grimley, Michael; Goyal, Rakesh K.; Boucher, Kenneth M.; Hankins, Patricia; Grupp, Stephan A.; Bunin, Nancy

Source: British Journal of Haematology, Volume 147, Number 5, December 2009 , pp. 691-699(9)

Publisher: Blackwell Publishing

Impaired pneumococcal immunity in children after treatment for acute lymphoblastic leukaemia

Authors: Lehrnbecher, Thomas; Schubert, Ralf; Behl, Michael; Koenig, Melanie; Rose, Markus A.; Koehl, Ulrike; Meisel, Roland; Laws, Hans-Jürgen

Source: British Journal of Haematology, Volume 147, Number 5, December 2009 , pp. 700-705(6)

Publisher: Blackwell Publishing

Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia

Authors: De Filippi, Paola; Zecca, Marco; Lisini, Daniela; Rosti, Vittorio; Cagioni, Claudia; Carlo-Stella, Carmelo; Radi, Orietta; Veggiotti, Pierangelo; Mastronuzzi, Angela; Acquaviva, Antonio; D'Ambrosio, Alfonso; Locatelli, Franco; Danesino, Cesare

Source: British Journal of Haematology, Volume 147, Number 5, December 2009 , pp. 706-709(4)

Publisher: Blackwell Publishing

ATG-saporin-S6 immunotoxin: a new potent and selective drug to eliminate activated lymphocytes and lymphoma cells

Authors: Polito, Letizia; Bortolotti, Massimo; Farini, Valentina; Pedrazzi, Manuela; Tazzari, Pier Luigi; Bolognesi, Andrea

Source: British Journal of Haematology, Volume 147, Number 5, December 2009 , pp. 710-718(9)

Publisher: Blackwell Publishing

Unexpected phenotype of a typical NPM1 mutant

Authors: Pianta, Annalisa; Fabbro, Dora; Damiani, Daniela; Tiribelli, Mario; Fanin, Renato; Franzoni, Alessandra; Romanello, Milena; Tell, Gianluca; Damante, Giuseppe

Source: British Journal of Haematology, Volume 147, Number 5, December 2009 , pp. 760-763(4)

Publisher: Blackwell Publishing

A new pattern of cytosine-arabinoside-induced lung toxicity

Authors: Chagnon, Karine; Boissel, Nicolas; Raffoux, Emmanuel; Dombret, Hervé; Tazi, Abdellatif; Bergeron, Anne

Source: British Journal of Haematology, Volume 147, Number 5, December 2009 , pp. 771-774(4)

Publisher: Blackwell Publishing

Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily

Authors: Sillaber, C.; Herrmann, H.; Bennett, K.; Rix, U.; Baumgartner, C.; Böhm, A.; Herndlhofer, S.; Tschachler, E.; Superti-Furga, G.; Jäger, U.; Valent, P.

Source: European Journal of Clinical Investigation, Volume 39, Number 12, December 2009 , pp. 1098-1109(12)

Publisher: Blackwell Publishing

Acquired Glanzmann's thrombasthenia associated with Hairy cell leukaemia

Authors: Kannan, M.; Chatterjee, T.; Ahmad, F.; Kumar, R.; Choudhry, V. P.; Saxena, R.

Source: European Journal of Clinical Investigation, Volume 39, Number 12, December 2009 , pp. 1110-1111(2)

Publisher: Blackwell Publishing

Betulin Elicits Anti-Cancer Effects in Tumour Primary Cultures and Cell Lines In Vitro

Authors: Rzeski, Wojciech; Stepulak, Andrzej; Szymański, Marek; Juszczak, Małgorzata; Grabarska, Aneta; Sifringer, Marco; Kaczor, Józef; Kandefer-Szerszeń, Martyna

Source: Basic & Clinical Pharmacology & Toxicology, Volume 105, Number 6, December 2009 , pp. 425-432(8)

Publisher: Blackwell Publishing